MACROGENICS INC - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-01-16

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-16	Common Stock	M	2476	$4.70	Acquired	32476	Direct
2018-01-16	Common Stock	S	2476	$20	Disposed	30000	Direct
2018-01-17	Common Stock	M	2524	$4.70	Acquired	32524	Direct
2018-01-17	Common Stock	S	2524	$20	Disposed	30000	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-16	Employee stock option (right to buy)	$4.7	M	2476	Disposed	2023-07-18	Common Stock (2476.0)	Direct
2018-01-17	Employee stock option (right to buy)	$4.7	M	2524	Disposed	2023-07-18	Common Stock (2524.0)	Direct

F1: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.

F3: This transaction was executed in multiple trades at prices ranging from $20 to $20.71.

F4: This transaction was executed in multiple trades at prices ranging from $20 to $20.03.